Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

Tolerability

Learn More

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T.

Cancer Chemother Pharmacol. 2012 Jan; 69 (1): 65-70.

TC002

Clinical

Safety evaluation of high bioavailability curcumin in Healthy Japanese Adults: A Randomized, placebo-controlled, double-blind, parallel-group comparison study

Tolerability

Learn More

Safety evaluation of high bioavailability curcumin in Healthy Japanese Adults: A Randomized, placebo-controlled, double-blind, parallel-group comparison study

Lee H, Kuwabara Y, Hirose A, Kakinuma T, Baba A, Takara T.

Funct Foods Health Dis. 2023;13(12):702-716.

TS003

Clinical

Safety Evaluation of Theracurmin® in Healthy Japanese Adults. ―A Randomized, Double-blind, Placebo-controlled Parallel-group Study―

Tolerability

Learn More

Safety Evaluation of Theracurmin® in Healthy Japanese Adults. ―A Randomized, Double-blind, Placebo-controlled Parallel-group Study―

Takahashi T, Iio S, Takara T.

Jpn Pharmacol Thervol. 2019 Jul 1; 47(7): 1097-1113.

 

TC035

Clinical